Literature DB >> 7873139

Depression: a long-term illness.

M B Keller1.   

Abstract

The realisation that major depression is often both chronic and recurrent has slowly begun to change the way that depression is diagnosed and treated. In particular, the need for continuation and maintenance treatment is an issue that now deserves increased attention, especially with the availability of new classes of antidepressant treatments, which have excellent efficacy and more favourable side-effect profiles. Although the serious consequences of depressive disorders clearly indicate the need for effective and prompt intervention on the part of clinicians, the results of several studies indicate that patients with depression consistently receive no or low levels of antidepressant therapy. It is hoped that, through continued education of health care provides and patients about the consequences of depression, the issue of undertreatment of this serious illness will be resolved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7873139

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  12 in total

1.  The nature of clinical depression: symptoms, syndromes, and behavior analysis.

Authors:  Jonathan W Kanter; Andrew M Busch; Cristal E Weeks; Sara J Landes
Journal:  Behav Anal       Date:  2008

2.  Neural network approaches to grade adult depression.

Authors:  Subhagata Chattopadhyay; Preetisha Kaur; Fethi Rabhi; U Rajendra Acharya
Journal:  J Med Syst       Date:  2011-07-21       Impact factor: 4.460

3.  Alcohol Use Disorder and the Persistence/Recurrence of Major Depression: Le trouble de l'usage de l'alcool et la persistance/récurrence de la dépression majeure.

Authors:  Vivian N Onaemo; Timothy O Fawehinmi; Carl D'Arcy
Journal:  Can J Psychiatry       Date:  2020-05-04       Impact factor: 4.356

4.  Depression after surgery for acoustic neuroma.

Authors:  G C Blomstedt; H Katila; M Henriksson; A Ekholm; J E Jääskeläinen; I Pyykko
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 5.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

Review 6.  Paroxetine: a review.

Authors:  M Bourin; P Chue; Y Guillon
Journal:  CNS Drug Rev       Date:  2001

7.  Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Khalaf Kridin; Yaron Sela; Arnon Cohen
Journal:  Acta Derm Venereol       Date:  2022-03-14       Impact factor: 3.875

8.  New statistical proposals to evaluate the benefit/risk ratio of long-term treatment of depression: application to a one-year double-blind study comparing medifoxamine with fluoxetine.

Authors:  P Lehert; M F Poirier-Littre; D Pringuey; A Galinowski
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

9.  Patterns of antidepressant prescriptions : I acute phase treatments.

Authors:  S Chakrabarti; P Kulhara
Journal:  Indian J Psychiatry       Date:  2000-01       Impact factor: 1.759

10.  Sensory Processing Disorders are Associated with Duration of Current Episode and Severity of Side Effects.

Authors:  Gianluca Serafini; Batya Engel-Yeger; Gustavo H Vazquez; Maurizio Pompili; Mario Amore
Journal:  Psychiatry Investig       Date:  2016-12-29       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.